This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

LHC Group (LHCG) Aktienübersicht

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. Mehr Details

LHCG grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	0/6
Künftiges Wachstum	4/6
Vergangene Leistung	2/6
Finanzielle Gesundheit	2/6
Dividenden	0/6

Belohnungen

Prognostiziertes Gewinnwachstum 37.23% pro Jahr

Risikoanalyse

Die Verschuldung ist durch den operativer Cashflow nicht gut gedeckt

Die Gewinnspannen (1.7%) sind niedriger als im Vorjahr (5.2%)

LHCG Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

LHC Group, Inc. Wettbewerber

Preisentwicklung & Leistung

Zusammenfassung der Höchst- und Tiefststände sowie der Veränderungen der Aktienkurse für LHC Group
Historische Aktienkurse
Aktueller Aktienkurs	US$169.81
52-Wochen-Hoch	US$169.84
52-Wochen-Tief	US$115.32
Beta	0.42
1 Monat Veränderung	3.76%
3 Monate Veränderung	0.91%
1 Jahr Veränderung	32.12%
3 Jahre Veränderung	30.61%
5 Jahre Veränderung	178.06%
Veränderung seit IPO	893.04%

Aktuelle Nachrichten und Updates

Recent updates

Seeking Alpha • Aug 03

LHC Group GAAP EPS of $0.35 misses by $0.95, revenue of $576.2M misses by $29.82M

LHC Group press release (NASDAQ:LHCG): Q2 GAAP EPS of $0.35 misses by $0.95. Revenue of $576.2M (+5.6% Y/Y) misses by $29.82M.

Seeking Alpha • Jul 19

LHC Group: UnitedHealth Merger Is Worth Playing

UnitedHealth’s ongoing acquisition of LHC Group is an interesting merger arbitrage setup, potentially offering an annualized return of 10%. The spread has recently widened as the transaction has attracted the FTC’s attention. The merger still seems likely to close - both companies have a low overlap, the home healthcare market is highly fragmented and the Humana-Kindred merger is a closely comparable transaction. The main risks are antitrust concerns over vertical integration and legal challenges to UnitedHealth’s ongoing merger with Change Healthcare. This is one of the ongoing large-cap merger arbitrage cases where the spread has recently widened. Healthcare and insurance giant UnitedHealth Group (UNH) is buying in-home healthcare company LHC Group (LHCG) at $170 per share. Board/shareholder approvals are already in-the-pocket. The only remaining hurdle is antitrust approval. Until recently, the market was not pricing in any regulatory risk as the spread was around 2%. In June, however, the merger received a second information request from the FTC. Since the news, the spread has jumped and is currently at 5%. In early July, rumors appeared that the FTC’s probe is focused on workers’ pay. Regulatory investigation is currently ongoing and the FTC will have 30 days to finish the review once the companies submit all the required information. Red dot represents FTC’s second request date. Yellow dot is where rumors appeared that FTC’s request is focused on labor pay. FTC’s inquiry comes in light of several industry developments. Firstly, UNH’s other ongoing $13bn merger with Change Healthcare (CHNG) has received pushback from the DoJ. The trial is set for August. However, CHNG operates in a different industry (medical billing software) than LHCG and the UHN-CHNG transaction has a much higher business overlap compared to UNH-LHCG merger. Secondly, since Joe Biden’s executive order on promoting competition in 2021, antitrust regulators have been putting increasing attention on healthcare mergers, highlighting impact on workers’ wages and the degree of vertical integration. These two concerns could be at play in the LHCG-UNH transaction. Also, as of May, the FTC has shifted to a majority-democratic commission, possibly pointing to tighter regulatory scrutiny. Despite these risks, I see several reasons why the LHCG merger is likely to receive regulatory clearance: UNH and LHCG have a low service overlap. The home healthcare market is highly fragmented. The Kindred-Humana merger is a comparable transaction in the home healthcare space. Recent FTC ruling history suggests that healthcare mergers are blocked due to geographical overlap/dominant market shares - largely not applicable to UNH-LHCG. Moreover, seemingly no mergers were blocked solely on labor pay grounds. Let’s go through these one-by-one. Limited Business Overlap LHCG operates in the post-acute healthcare market. The primary focus is on home-based healthcare services which have historically made a lion’s share of revenues at ~80%. This includes two reportable segments - home health (~70%) and home-/community-based care (~10%). The company operates home nursing agencies through which it provides post-acute nursing, medically-oriented social services and therapy. Other segments (~20% of revenues) are hospices, facility-based healthcare services and other healthcare businesses. Meanwhile, UNH is a vertically-integrated multinational company - it runs both health insurance (UnitedHealthcare) and health services (Optum) businesses. The Optum arm provides a continuum of healthcare services, including primary care, virtual care, behavioral health and ambulatory surgery. Even so, the company’s presence in the post-acute in-home care market has been limited. Apparently, ever since the pandemic, UNH has sought to expand the segment. Still, some overlap with LHCG remains - UNH launched its own service HouseCalls as well as acquired start-ups Landmark Health and naviHealth. HouseCalls in an annual in-home medical assessment and not a post-acute care service. Having said that, the number of patient visits in 2021 were at ~2.1m compared to 12m+ patient encounters at LHCG, though the latter include hospice patients. NaviHealth is a software business. The company operates a platform which helps hospital systems and healthcare providers manage clinical decision-making and track patient data. It should be noted that the focus is also on post-acute healthcare services. Landmark Health provides in-home care, however, the focus is exclusively on the sickest and most complicated patients. Services are offered in addition to regular primary care providers, such as LHCG. As of 2019, the number of annual visits was at 400k. Home-Care Market The in-home care market in the US is highly fragmented. To illustrate this, the largest market share captured by Kindred at Home (not publicly-listed) in recent years has been stable at only around 6% while other largest peers (Amedisys and Encompass) have occupied only ~4%-~5%. Company LHCG AMED EHC Kindred at Home Market Cap 5.0 4.1 4.9 Enterprise Value 5.8 4.5 8.0 FY2021 Home Care Revenues ($bn) 1.6 1.4 0.9 Market Share 4.4% 5.0% 3.9% 6.0% Sources: Company filings and HealthCare Appraisers. LexisNexis Visually, LHCG (top-right) appears to cover similar geographies as the largest peers Kindred, Amedisys and Encompass: AMED 8-K Filing, LHCG Investor Presentation, EHC Investor Reference Book, Kindred Healthcare Investor Presentation (Kindred acquired Gentiva in 2015) Looking more specifically, LHCG’s share of the number of home care agencies in several states is significant at ~70% in Mississippi and ~50% in Kentucky. However, these areas have relatively low numbers of total home care providers. Plus, total agency number includes only Medicare-registered providers whose count stands at ~11k compared to a rough estimate of ~35k+ including non-licensed agencies. With this in mind, the merger is unlikely to result in UNH obtaining any alarming market power other than in several specific geographies where divestitures, if needed, could be reasonable to expect. This makes any antitrust pushback very unlikely.

Seeking Alpha • Jul 06

FTC second request in LHC Group/UnitedHealth said to probe pay, labor market

The FTC's second request into UnitedHealth's (NYSE:UNH) planned $5.4 billion purchase of LHC Group (NASDAQ:LHCG) is said to be centered on workers' pay in the home healthcare space. The companies received a second request early last month that was unexpected, according to a Dealreporter item, which cited sources familiar. Kindred Healthcare's sale to Apollo Global also received a second request from the FTC. The FTC is said to be looking at how pay in the healthcare space and how minimum wage workers have trouble bargaining for higher wages, according to the report. UnitedHealth (UNG) agreed to buy home health business LHC Group for $170/share in late March.

Aktionärsrenditen

	LHCG	US Healthcare	US Markt
7D	0.6%	-1.3%	1.5%
1Y	32.1%	12.4%	28.6%

Rendite im Vergleich zur Industrie: LHCG übertraf die Branche US Healthcare , die im vergangenen Jahr eine Rendite von 12.4 erzielte.

Rendite vs. Markt: LHCG übertraf den Markt US, der im vergangenen Jahr eine Rendite von 28.6 erzielte.

Preisvolatilität

Is LHCG's price volatile compared to industry and market?
LHCG volatility
LHCG Average Weekly Movement	2.1%
Healthcare Industry Average Movement	7.3%
Market Average Movement	7.2%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.0%

Stabiler Aktienkurs: LHCG hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.

Volatilität im Zeitverlauf: LHCGDie wöchentliche Volatilität (2%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1994	23,000	Keith Myers	www.lhcgroup.com

LHC Group, Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von LHC Group im Vergleich zum Marktanteil des Unternehmens?
LHCG grundlegende Statistiken
Marktanteil	US$5.29b
Gewinn(TTM)	US$39.87m
Umsatz(TTM)	US$2.28b

132.7x

Kurs-Gewinn-Verhältnis

2.3x

Kurs-Umsatz-Verhältnis

Ist LHCG zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
LHCG Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$2.28b
Kosten der Einnahmen	US$1.40b
Bruttogewinn	US$883.61m
Sonstige Ausgaben	US$843.74m
Gewinn	US$39.87m

Zuletzt gemeldete Gewinne

Dec 31, 2022

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	1.28
Bruttomarge	38.71%
Nettogewinnspanne	1.75%
Schulden/Eigenkapital-Verhältnis	43.0%

Wie hat sich LHCG auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2023/02/23 20:55
Aktienkurs zum Tagesende	2023/02/21 00:00
Gewinne	2022/12/31
Jährliche Einnahmen	2022/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

LHC Group, Inc. wird von 21 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Matthew Gillmor	Baird
Steven Valiquette	Barclays
Sarah James	Barclays

This company has been acquired

LHC Group (LHCG) Aktienübersicht

Belohnungen

Risikoanalyse

LHC Group, Inc. Wettbewerber

Option Care Health

Chemed

CorVel

Premier

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Insufficient new directors

Consensus EPS estimates fall by 20%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

LHC Group, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Recent updates

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Insufficient new directors

Consensus EPS estimates fall by 20%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

LHC Group, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Consensus forecasts updated

Consensus forecasts updated

LHC Group, Inc. (NasdaqGS:LHCG) announced an agreement to acquire Three Rivers Home Health Services, Inc.

Consensus EPS estimates fall by 35%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

LHC Group GAAP EPS of $0.35 misses by $0.95, revenue of $576.2M misses by $29.82M

LHC Group: UnitedHealth Merger Is Worth Playing

LHC Group, Inc. to Report Q2, 2022 Results on Aug 03, 2022

FTC second request in LHC Group/UnitedHealth said to probe pay, labor market

First quarter 2022 earnings: EPS misses analyst expectations

Insufficient new directors

LHC Group, Inc. to Report Q1, 2022 Results on May 04, 2022

Insufficient new directors

OptumHealth, Inc. entered into a definitive agreement to acquire LHC Group, Inc. (NasdaqGS:LHCG) for $5.5 billion.

Full year 2021 earnings: EPS misses analyst expectations

LHC Group, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022

Executive VP & General Counsel recently sold US$100k worth of stock

Investor sentiment improved over the past week

LHC Group, Inc. (NasdaqGS:LHCG) announces an Equity Buyback for $250 million worth of its shares.

Third quarter 2021 earnings released: EPS US$0.89 (vs US$0.47 in 3Q 2020)

Price target decreased to US$212

Price target decreased to US$222

LHC Group, Inc. (NasdaqGS:LHCG) agreed to acquire Generations Home Health.

LHC Group, Inc. (NasdaqGS:LHCG) acquired Heart of Hospice, LLC from Evening Post Industries, Inc.

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS US$1.21 (vs US$1.44 in 2Q 2020)

LHC Group, Inc. (NasdaqGS:LHCG) completed the acquisition of Cavalier Healthcare Services Inc.

LHC Group, Inc. (NasdaqGS:LHCG) entered into an agreement to acquire Ashley County Medical Center Home Health.

Lead Independent Director Wilbert Tauzin has left the company

LHC Group, Inc. (NasdaqGS:LHCG) signed a definitive agreement to acquire Heart of Hospice, LLC from Evening Post Industries, Inc.

Independent Director recently sold US$1.0m worth of stock

LHC Group, Inc. (NasdaqGS:LHCG) entered into an agreement to acquire Heart ‘n Home Hospice & Palliative Care, LLC.

LHC Group, Inc. (NasdaqGS:LHCG) agreed to acquire two hospice care provider in Tucson from La Casa de la Raza, Inc.

First quarter 2021 earnings released: EPS US$1.11 (vs US$0.71 in 1Q 2020)

LHC Group, Inc. Raises Revenue Guidance for the Full Year 2021

LHC Group, Inc. (NasdaqGS:LHCG), Texas Health Resources Inc. and North Texas Health Facilities Management, Inc entered into an agreement to acquire Regent Home Health.

Lhc Group and Orlando Health Expands Partnership in Florida

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS US$3.59 (vs US$3.10 in FY 2019)

New 90-day low: US$188

LHC Group, Inc., Annual General Meeting, Jun 10, 2021

LHC Group, Inc. to Report Q4, 2020 Results on Feb 25, 2021

LHC Group, Inc. (NasdaqGS:LHCG) completed the acquisition of East Valley Hospice and East Valley Palliative Care.

New 90-day low: US$196

LHC Group, Inc. (NasdaqGS:LHCG) agreed to acquire Grace Hospice Of Oklahoma.

Analysts update estimates

LHC Group, Inc. (NasdaqGS:LHCG) entered into an agreement to acquire East Valley Hospice and East Valley Palliative Care.

Revenue beats expectations, earnings disappoint

Third quarter 2020 earnings released: EPS US$0.47

LHC Group, Inc. Revises Earnings Guidance for the Full Year 2020

LHC Group, Inc. Appoints Dale G. Mackel to Serve as its Executive Vice President and Treasurer

LHC Group and CHRISTUS Health Expand Joint Venture Partnership in Texas

LHC Group, Inc. to Report Q3, 2020 Results on Nov 04, 2020

Lhc Group, Inc. Finalizes Two New Joint Venture Agreements in Georgia, Purchases Colorado Hospice Provider

LHC Group, Inc. (NasdaqGS:LHCG) completed the acquisition of unknown minority stake in Norton Healthcare, Inc.

LHC Group, Inc. (NasdaqGS:LHCG) completed the acquisition of Home Health and Home and Community Based Services from VNA of Maryland and Elite Home Care Services.